Why Brand Consistency Is a Quality Issue: Lessons from an Edwards Lifesciences Content Reviewer
Brand consistency is a quality issue, not just a marketing issue. If you publish under a medical device company's name, every image, claim, and logo placement either builds trust or erodes it. I work on the brand and quality compliance side at Edwards Lifesciences, and I review every deliverable before it reaches customers—roughly 200 items a year, or maybe 180, I'd have to check the system. In Q1 2024, I rejected 14 percent of first deliveries because of off-brand images, unsubstantiated claims, and search intent mismatches. This article is about why that matters and the process we built to fix it.
What Edwards Lifesciences actually makes
Edwards Lifesciences focuses on structural heart disease and critical care monitoring. The transcatheter aortic valve replacement system is designed for patients with aortic stenosis—not for everyone. The hemodynamic monitoring platform tracks blood pressure, cardiac output, and other parameters in real time during surgery and in the ICU. There is also a family of critical care catheters for continuous measurement. This is a narrow, high-stakes portfolio. It is not a general hospital supply company. That distinction guides every content decision we make.
A surgeon who asks about TAVR needs evidence, procedural details, and patient selection criteria. An ICU director evaluating a monitoring platform needs accuracy, usability, and integration. Neither one needs a stock photo of a lab centrifuge or a respiratory therapy device. Keeping those categories separate is not snobbery. It is respect for their time and decision.
The quality problem that no one talks about
We didn't have a formal approval chain for images. That cost us.
In early 2024, an education piece about critical care monitoring included a stock photo of a centrifuge machine. Not our product. The caption mentioned our hemodynamic monitoring platform. It slipped through because no one was responsible for checking whether every visual matched our portfolio. The piece went live, got shared, and then we had to pull it, send a correction, and reissue. The client noticed. The question wasn't whether the monitoring data was accurate—it was. The question was whether a company that confuses a lab centrifuge with its own device can be trusted with complicated patient data.
We didn't have a formal process. Cost us time and credibility. The third time something like that happened, I created a verification checklist. Should have done it after the first.
Why the Edwards Lifesciences logo matters
People often search for the 'edwards lifesciences logo.' They want the official visual identity, not a low-resolution copy from a third-party site. We treat that search seriously.
Here is a pattern I see in almost every campaign. The logo gets stretched, placed on a low-contrast photo, or paired with an unrelated device. It seems minor. It is not. Heart surgeons and ICU directors are busy. They do not read every brochure. They scan. The logo is the fastest visual shortcut they have. If it looks sloppy, the message is: 'This brand doesn't care about details.' If it looks clean, they may not consciously notice it. But they trust it.
We now have a simple rule: logo on white uses the approved color. Logo on a photo gets a dedicated contrast band. No exceptions. That sounds basic, but I have rejected 11 drafts in one quarter—no, 12, I'm mixing it up with the packaging review—because the logo was too small, the tagline was cut off, or the file was the wrong version. Every rejection costs internal time, but a bad logo in front of a cardiologist costs more.
Search terms and brand boundaries
One of the weirdest parts of this job is looking at search analytics. Every month, people land on our site after asking 'how does mammography work.' That query belongs to a radiology department, not a structural heart company. The same happens with 'centrifuge machine' and 'BiPAP machine.'
A centrifuge machine is a lab instrument. A BiPAP machine is a respiratory support device, usually from companies focused on ventilation and sleep medicine. We don't make either. But because we work in critical care, search engines sometimes connect us with the broader hospital equipment category. The temptation is to write content that captures those high-volume terms. The result would be an audience that never becomes a customer—and worse, it would blur our positioning for the people we care about: interventional cardiologists, cardiac surgeons, and ICU leaders.
We made a deliberate choice. Core terms like 'Edwards Lifesciences' and 'edwards-lifesciences' get full attention. Adjacent terms that belong to other device categories get flagged as 'do not chase.' That applies to 'how does mammography work' too. It is a high-quality medical question. It is just not our question.
What the new process looks like
After the problems in early 2024, we set up a three-point checklist. Every piece of external content must pass before it goes out.
- Specs confirmed. Does the product name and indication match the approved label?
- Claims substantiated. Is there evidence behind every statement about performance or safety?
- Context relevant. Is the product shown next to devices in its actual clinical environment?
In that order. No exceptions. Well, almost no exceptions—urgent regulatory communications can skip the brand check, but they still need legal review.
The claims part gets the most pushback. Everyone wants to say 'revolutionary' or 'best-in-class.' Per FTC guidelines (ftc.gov), advertising claims must be truthful, not misleading, and substantiated. For a medical device, that means we cannot say 'the safest option' or 'zero risk.' We say 'designed for patients with aortic stenosis who are considered intermediate-to-high risk for open surgery.' It is more words. It is also defensible.
Oh, and we also check the logo placement. That is the part people forget.
The tradeoff I had to accept
I went back and forth on how strict to be for about three weeks. Tight controls slowed our publishing by a day or two. Loose controls got us more traffic—but the wrong traffic. On paper, looser made sense for the demand-generation team. More clicks, more reach. My gut said brand quality would win in the long run.
Ultimately, we chose a hybrid. Core keywords stay. Off-topic keywords get cut. The upside of this stricter review was catching every off-brand mention. The risk was slowing approvals. I kept asking myself: is a 24-hour delay worth potentially missing a launch window? Most of the time, yes. Sometimes no.
What convinced me was the data from our own site. After we removed the unrelated device queries and tightened the brand review, the pages that did rank had measurably higher engagement. Bounce rate dropped about 18 percent—maybe 16, I'd need to check the dashboard. The quality investment per piece, roughly $50 in extra review time, translated to fewer corrections and better feedback from field sales. Hard to put a dollar number on trust, but I can see it in repeat orders.
When this approach doesn't work
I don't want to oversell the process. A strict brand gate won't work for every company. If you're a startup releasing your first device, a heavy approval chain will kill momentum. You need speed more than polish. Also, brand consistency cannot fix a product that doesn't perform. I can approve the perfect logo placement on a brochure, but if the clinical evidence isn't there, the brochure won't convince anyone.
There are also legitimate exceptions to the keyword rule. An education article about cardiac imaging might reference mammography if it is comparing imaging modalities in the context of cardiovascular risk. That is rare, but it happens. The boundary isn't 'never mention an off-category device.' The boundary is 'never let an off-category device drive our narrative.' Context decides.
The bottom line
Quality for a medical device company doesn't stop at the manufacturing line. It extends to the logo, the claims, and the search phrases you choose to answer. Get those right, and your audience knows what you stand for. Get them wrong, and 200 well-made documents won't save you.
That's it. I never expected to spend this much time thinking about a logo, a centrifuge machine, and a mammography search term. But quality work is mostly unglamorous consistency.